An experimental Alzheimer's vaccine slowed symptoms in animals.

The new vaccine works by targeting a protein that appears in aging cells if they stop dividing and cause inflammation, and the body cannot remove them on its own. The mice received the drug at two and four months of age, then the researchers tested them in a maze at six months. The vaccinated animals showed significant improvements in behavioral tests.